Literature DB >> 1260694

The natural history of nodular lymphoma.

R Qazi, A C Aisenberg, J C Long.   

Abstract

The clinical and histopathologic characteristics of 65 patients with nodular lymphoma seen at the Massachusetts General Hospital between 1962 and 1972 were reviewed. Five years after diagnosis 54% of these patients were alive, but only 18 percent remained free of disease. Younger patients fared much better (64 percent of those below the age of 50 survived 5 years) than the elderly (only 34 percent of those above the age of 50 survived this long), but histologic subtype by the Rappaport classification was not useful in predicting survival in this series. Individuals with localized disease (80% of those in Stages I and II survived 5 years) experienced better survival than those with dissemination (only 45% of those in Stages III and IV lived this long), but the high relapse rate in Stages I and II indicates that few who presented with localized disease are cured. At the time of death, the histologic pattern had become diffuse in 8 of 18 patients but remained nodular in the other 10. Ten patients treated by total nodal irradiation followed the same survival curve as the remainder treated less radically. It is concluded that nodular lymphoma is an indolent but usually fatal entity: though more than half of our patients survived 5 years, few were cured by the treatments employed.

Entities:  

Mesh:

Year:  1976        PMID: 1260694     DOI: 10.1002/1097-0142(197604)37:4<1923::aid-cncr2820370443>3.0.co;2-d

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

Review 1.  Transformation of follicular lymphoma.

Authors:  Izidore S Lossos; Randy D Gascoyne
Journal:  Best Pract Res Clin Haematol       Date:  2011-05-06       Impact factor: 3.020

2.  Non-hodgkin's lymphomas in Saskatchewan: a clinicopathologic study.

Authors:  T Cherian; L F Skinnider; J L Wright; G Komjathy
Journal:  Can Med Assoc J       Date:  1978-09-09       Impact factor: 8.262

3.  Comparison of combined and single-agent chemotherapy in non-Hodgkin's lymphoma of favourable histological type.

Authors:  T A Lister; M H Cullen; M E Beard; R L Brearley; J M Whitehouse; P F Wrigley; A G Stansfeld; S B Sutcliffe; J S Malpas; D Crowther
Journal:  Br Med J       Date:  1978-03-04

4.  Indolent lymphoma with composite histology and simultaneous transformation at initial diagnosis exhibit clinical features similar to de novo diffuse large B-cell lymphoma.

Authors:  Hanno Witte; Harald Biersack; Svenja Kopelke; Dirk Rades; Hartmut Merz; Veronica Bernard; Hendrik Lehnert; Niklas Gebauer
Journal:  Oncotarget       Date:  2018-04-13

5.  Histological, epidemiological and clinical aspects of centroblastic-centrocytic lymphomas subdivided according to the "working formulation".

Authors:  W M Molenaar; H Bartels; J Koudstaal
Journal:  Br J Cancer       Date:  1984-03       Impact factor: 7.640

Review 6.  Malignant lymphomas as tumours of the immune system.

Authors:  C W Berard; J Cossman; E S Jaffe
Journal:  Br J Cancer       Date:  1980-07       Impact factor: 7.640

7.  Transformation of follicular lymphoma to double hit B-cell lymphoma causing hypercalcemia in a 69-year-old female: a case report and review of the literature.

Authors:  Sakshi Kapur; Miles B Levin
Journal:  Case Rep Hematol       Date:  2014-08-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.